Share-based Payment Arrangement, Expense of Voyager Therapeutics, Inc. from 30 Sep 2014 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Voyager Therapeutics, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2014 to 30 Sep 2025.
  • Voyager Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $3,460,000, a 0.76% increase year-over-year.
  • Voyager Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $15,002,000, a 6.4% increase year-over-year.
  • Voyager Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $14,785,000, a 33% increase from 2023.
  • Voyager Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $11,153,000, a 19% increase from 2022.
  • Voyager Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $9,344,000, a 17% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Voyager Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $15,002,000 $3,460,000 +$26,000 +0.76% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $14,976,000 $4,133,000 +$91,000 +2.3% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $14,885,000 $3,673,000 +$100,000 +2.8% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $14,785,000 $3,736,000 +$691,000 +23% 01 Oct 2024 31 Dec 2024 10-K 11 Mar 2025 2024 FY
Q3 2024 $14,094,000 $3,434,000 +$556,000 +19% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025 2025 Q3
Q2 2024 $13,538,000 $4,042,000 +$1,370,000 +51% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 $12,168,000 $3,573,000 +$1,015,000 +40% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q4 2023 $11,153,000 $3,045,000 +$699,000 +30% 01 Oct 2023 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q3 2023 $10,454,000 $2,878,000 +$689,000 +31% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $9,765,000 $2,672,000 +$182,000 +7.3% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 $9,583,000 $2,558,000 +$239,000 +10% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q4 2022 $9,344,000 $2,346,000 +$691,000 +42% 01 Oct 2022 31 Dec 2022 10-K 11 Mar 2025 2024 FY
Q3 2022 $8,653,000 $2,189,000 +$112,000 +5.4% 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023 2023 Q3
Q2 2022 $8,541,000 $2,490,000 -$1,501,000 -38% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2023 Q2
Q1 2022 $10,042,000 $2,319,000 -$1,282,000 -36% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $11,324,000 $1,655,000 -$1,848,000 -53% 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
Q3 2021 $13,172,000 $2,077,000 -$1,455,000 -41% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 $14,627,000 $3,991,000 +$132,000 +3.4% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q2
Q1 2021 $14,495,000 $3,601,000 -$439,000 -11% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q4 2020 $14,934,000 $3,503,000 -$16,000 -0.46% 01 Oct 2020 31 Dec 2020 10-K 07 Mar 2023 2022 FY
Q3 2020 $14,950,000 $3,532,000 +$183,000 +5.5% 01 Jul 2020 30 Sep 2020 10-Q 02 Nov 2021 2021 Q3
Q2 2020 $14,767,000 $3,859,000 -$1,395,000 -27% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021 2021 Q2
Q1 2020 $16,162,000 $4,040,000 +$522,000 +15% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q4 2019 $15,640,000 $3,519,000 +$881,000 +33% 01 Oct 2019 31 Dec 2019 10-K 08 Mar 2022 2021 FY
Q3 2019 $14,759,000 $3,349,000 +$713,000 +27% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020 2020 Q3
Q2 2019 $14,046,000 $5,254,000 -$2,860,000 -35% 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020 2020 Q2
Q1 2019 $16,906,000 $3,518,000 +$1,196,000 +52% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q4 2018 $15,710,000 $2,638,000 +$344,000 +15% 01 Oct 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
Q3 2018 $15,366,000 $2,636,000 -$605,000 -19% 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019 2019 Q3
Q2 2018 $15,971,000 $8,114,000 +$6,576,000 +428% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019 2019 Q2
Q1 2018 $9,395,000 $2,322,000 +$157,000 +7.3% 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019 2019 Q1
Q4 2017 $9,238,000 $2,294,000 +$513,000 +29% 01 Oct 2017 31 Dec 2017 10-K 03 Mar 2020 2019 FY
Q3 2017 $8,725,000 $3,241,000 +$1,452,000 +81% 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018 2018 Q3
Q2 2017 $7,273,000 $1,538,000 +$220,000 +17% 01 Apr 2017 30 Jun 2017 10-Q 07 Aug 2018 2018 Q2
Q1 2017 $7,053,000 $2,165,000 +$743,000 +52% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q4 2016 $6,310,000 $1,781,000 -$185,000 -9.4% 01 Oct 2016 31 Dec 2016 10-K 26 Feb 2019 2018 FY
Q3 2016 $6,495,000 $1,789,000 +$932,000 +109% 01 Jul 2016 30 Sep 2016 10-Q 02 Nov 2017 2017 Q3
Q2 2016 $5,563,000 $1,318,000 +$416,000 +46% 01 Apr 2016 30 Jun 2016 10-Q 08 Aug 2017 2017 Q2
Q1 2016 $5,147,000 $1,422,000 +$1,120,000 +371% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q4 2015 $4,027,000 $1,966,000 01 Oct 2015 31 Dec 2015 10-K 14 Mar 2018 2017 FY
Q3 2015 $857,000 +$689,000 +410% 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016 2016 Q3
Q2 2015 $902,000 01 Apr 2015 30 Jun 2015 10-Q 11 Aug 2016 2016 Q2
Q1 2015 $302,000 01 Jan 2015 31 Mar 2015 10-Q 12 May 2016 2016 Q1
Q3 2014 $168,000 01 Jul 2014 30 Sep 2014 10-Q 17 Dec 2015 2015 Q3

Voyager Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $14,785,000 +$3,632,000 +33% 01 Jan 2024 31 Dec 2024 10-K 11 Mar 2025 2024 FY
2023 $11,153,000 +$1,809,000 +19% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025 2024 FY
2022 $9,344,000 -$1,980,000 -17% 01 Jan 2022 31 Dec 2022 10-K 11 Mar 2025 2024 FY
2021 $11,324,000 -$3,610,000 -24% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $14,934,000 -$706,000 -4.5% 01 Jan 2020 31 Dec 2020 10-K 07 Mar 2023 2022 FY
2019 $15,640,000 -$70,000 -0.45% 01 Jan 2019 31 Dec 2019 10-K 08 Mar 2022 2021 FY
2018 $15,710,000 +$6,472,000 +70% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
2017 $9,238,000 +$2,928,000 +46% 01 Jan 2017 31 Dec 2017 10-K 03 Mar 2020 2019 FY
2016 $6,310,000 +$2,283,000 +57% 01 Jan 2016 31 Dec 2016 10-K 26 Feb 2019 2018 FY
2015 $4,027,000 +$3,602,000 +848% 01 Jan 2015 31 Dec 2015 10-K 14 Mar 2018 2017 FY
2014 $425,000 01 Jan 2014 31 Dec 2014 10-K 15 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.